Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Duchenne Muscular Dystrophy · Muscular Dystrophies · CAPR

CAPRICOR THERAPEUTICS

CAPRICOR THERAPEUTICS, INC.

CAPRICOR THERAPEUTICS patent portfolio — 43 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
San Diego, USA HQ
2005 Founded
240 Employees
Public company Type
CAPR · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Founded
2005
Employees
240
Programs
8
Drugs
6
Patents
43
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

CAPRICOR THERAPEUTICS patents

43 pharmaceutical patents indexed for CAPRICOR THERAPEUTICS. 2 expire within 24 months.

CAPRICOR THERAPEUTICS has 43 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

43 patents

Patent portfolio

  1. US 11801268

    Methods of treating ocular inflammation and chemical injuries of the eye with extracellular vesicles

    Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11759482

    Methods and compositions for treating skeletal muscular dystrophy

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10695293

    Method of preventing or treating radiation-induced dermatitis with extracellular vesicles

    Expires Mon Jun 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10369173

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9884076

    Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy

    Expires Mon Feb 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9623085

    Chimeric natriuretic peptide compositions and methods of preparation

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9616107

    Therapy for kidney disease and/or heart failure

    Expires Mon Apr 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9314507

    Methods of treatment of heart failure with natriuretic peptides

    Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8202538

    Orally disintegrating layered compositions

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7678387

    Drug delivery systems

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7229641

    Rapid-melt compositions methods of making same and methods of using same

    Expires Mon Jun 07 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7163700

    Amorphous drug beads

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 6589556

    Rapid-melt semi-solid compositions, methods of making same and methods of using same

    Expires Mon Jul 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6555145

    Alternate encapsulation process and products produced therefrom

    Expires Mon Apr 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6406717

    Rapid-melt semi-solid compositions, methods of making same and methods of using same

    Expires Mon Jun 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6399627

    Inhibitors of factor Xa

    Expires Mon May 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6376515

    Benzamides and related inhibitors of factor Xa

    Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6375982

    Rapid-melt semi-solid compositions, methods of making same and method of using same

    Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6369080

    Selective factor Xa inhibitors

    Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6369063

    Selective factor Xa inhibitors

    Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6333321

    Selective factor Xa inhibitors

    Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6297026

    Nucleic acids encoding the C140 receptor

    Expires Mon Sep 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6291469

    Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation

    Expires Mon Sep 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6262047

    Selective factor Xa inhibitors

    Expires Mon Jul 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6245743

    Inhibitors of factor Xa

    Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6228854

    Selective factor Xa inhibitors

    Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6218382

    Selective factor Xa inhibitors

    Expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6210913

    Modulation of integrin-mediated signal transduction

    Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6211154

    Ketoheterocyclic inhibitors of factor Xa

    Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6211183

    Selective factor Xa inhibitors

    Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6204268

    Selective factor Xa inhibitors

    Expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6197748

    Ketoheterocyclic inhibitors of factor Xa

    Expires Mon Mar 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6194557

    Nucleic acid molecules encoding Bap-1 proteins

    Expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6133256

    Selective factor Xa inhibitors

    Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6117836

    Glycosylation-mediated inhibition of factor X

    Expires Mon Sep 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6083688

    Platelet glycoprotein V gene and uses

    Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6069130

    Ketoheterocyclic inhibitors of factor Xa

    Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6063794

    Selective factor Xa inhibitors

    Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6063582

    Methods of screening for compounds that interact with human P.sub.2u2 purinergic receptor

    Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6060588

    Bap-1 proteins

    Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6046169

    Inhibitors of factor XA

    Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6043212

    Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

    Expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6022861

    Ketoheterocyclic inhibitors of factor Xa

    Expires Mon Feb 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does CAPRICOR THERAPEUTICS have?

43 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CAPRICOR THERAPEUTICS patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.